New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
16:24 EDTC, TWTR, EW, MDT, GDP, AKBA, NQ, RTRXOn The Fly: Closing Wrap
Stocks on Wall Street were higher after U.S. retail sales for March surprised to the upside. The averages spent much of the session higher before losing altitude during the afternoon, with the Nasdaq even turning negative near 3:00 pm ET. An aggressive rally took hold in the final 30 minutes of trade, with the indexes closing just off their best levels of the day. ECONOMIC EVENTS: In the U.S., retail sales climbed 1.1% in March, beating expectations for an increase of 0.8%. Retail sales excluding autos rose 0.7%, which also beat estimates. Business inventories grew 0.4% in February, versus the consensus forecast for a 0.5% gain. In Europe, industrial production across the 18 country shared currency bloc rose by 0.2% in February from the prior month and by 1.7% from the same month of the prior year. COMPANY NEWS: Citigroup (C) gained $1.99, or 4.36%, to $47.67 after its adjusted first quarter earnings easily beat the consensus forecast. CEO Michael Corbat said the company delivered strong results despite a quarter "that was difficult," which included the bank surprisingly having its capital plan rejected by the Federal Reserve and the disclosure of fraud in its Mexican unit... Twitter (TWTR) shares held up better than they have in recent sessions after its co-founders, Jack Dorsey and Evan Williams, along with CEO Richard Costolo, disclosed that they have no plans to sell any of their shares as part of the May 5 lockup expiration... Edwards Lifesciences (EW) gained $8.03, or 11.0%, to $81.00 after being granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the U.S. due to patent infringement. The ruling triggered upgrades of Edwards' shares from at least two analyst firms. Medtronic, which received at least one downgrade following the news, slipped $1.12, or 1.89%, to $58.08. MAJOR MOVERS: Among the notable gainers was Goodrich Petroleum (GDP), which surged $5.56, or 30.22%, to $23.96 after the company reported strong results for a well it drilled in Louisiana. Also higher was Akebia (AKBA), which rose $4.28, or 25.39%, to $21.14 after no fewer than four analyst firms initiated coverage on the shares with a Buy or equivalent rating. Among the noteworthy losers was NQ Mobile (NQ), which fell another $1.65, or 12.99%, to $11.05, adding to the 20% decline it suffered Friday after the company disclosed accounting errors along with its mixed earnings report. Short-seller Muddy Waters, which revealed a public short position on NQ in October, released a report today saying NQ's disappointing quarter was driven by heightened auditor scrutiny. Also lower Retrophin (RTRX), which dropped $2.35, or 15.3%, to $13.01 despite raising its fiscal 2014 revenue view after announcing that the FDA is unwilling to grant expedited access for children to the company's RE-024 treatment. INDEXES: The Dow was up 146.49, or 0.91%, to 16,173.24, the Nasdaq was up 22.96, or 0.57%, to 4,022.69, and the S&P 500 was up 14.92, or 0.82%, to 1,830.61.
News For C;TWTR;EW;MDT;GDP;AKBA;NQ;RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 22, 2014
09:32 EDTMDTMedtronic announces CE Mark, European launch for TYRX envelope
Medtronic has received CE, or Conformité Européenne, Mark for the TYRX Absorbable Antibacterial Envelope, which covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections.
September 20, 2014
21:15 EDTCCitigroup and Argentina's appeal on bond case dismissed, Reuters says
Subscribe for More Information
September 19, 2014
16:00 EDTTWTROptions Update; September 19, 2014
Subscribe for More Information
11:25 EDTMDTSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
11:24 EDTTWTRTD Ameritrade:Alibaba premarket orders approaching Facebook levels, Reuters says
Subscribe for More Information
11:14 EDTCSumitomo Mitsui, Mitsubishi UFJ on short list for Citigroup unit, WSJ reports
Sumitomo Mitsui Financial Group (SMFG), Sumitomo Mitsui Trust Holding, Mitsubishi UFJ Financial (MTU) and Shinsei Bank have been shortlisted by Citigroup (C) as buyers for the U.S. bank's retail bank in Japan, the Wall Street Journal reports, citing sources. Citi could pick a buyer for the unit by the end of the year or early next year. Citigroup could sell its Diners Club branded credit card unit in Japan along with the retail bank, a source says. Reference Link
09:37 EDTCActive equity options trading on open
Subscribe for More Information
07:17 EDTCCitigroup up against hard situation in Argentina bond plea, Reuters says
Subscribe for More Information
September 18, 2014
14:08 EDTCBanks look to high-interest personal loans to boost revenue, WSJ says
Subscribe for More Information
12:18 EDTMDTNY AG announces national settlement with Medtronic for Medicaid violations
Attorney General Eric T. Schneiderman announced that 46 states and the District of Columbia have reach a settlement agreement with Minnesota-based company Medtronic to resolve claims under the False Claims Act that Medtronic improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease. New York led a national team composed of members from Oregon, Texas and California to negotiate the settlement. The federal government settled its matter in May of this year...The agreement requires Medtronic to pay the settling states $362,362, which will go to those states’ Medicaid programs. The matter was brought by a whistleblower, Adolfo Schroeder, and was filed in U.S. District Court for the Eastern District of California. The Attorney General would like to thank Mr. Schroeder for bringing this matter to the government’s attention. Under the terms of the agreement, the New York Medicaid Program will receive $67,369.31. Reference Link
09:36 EDTTWTRActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
09:19 EDTEWGeneration Investment reports 5.2% passive stake in Edwards Lifesciences
September 17, 2014
16:00 EDTTWTROptions Update; September 17, 2014
iPath S&P 500 VIX Short-Term Futures down 24c to 27.63. Option volume leaders: AAPL TSLA BAC TWTR AMZN X WLT KO PBR according to Track Data.
13:16 EDTCHolder says DOJ looking to charge bank executives, Washington Post says
Subscribe for More Information
09:36 EDTTWTRActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL WFM X YHOO TSLA TWTR RAX SHLD SPLS
09:10 EDTRTRXOn The Fly: Pre-market Movers
Subscribe for More Information
09:08 EDTMDTMedtronic launches new Balloon Kyphoplasty Platform
Subscribe for More Information
07:43 EDTMDTBofA/Merrill to hold a conference
Subscribe for More Information
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
05:53 EDTNQStocks with implied volatility movement; YHOO NQ
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use